Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 463
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Drug Discovery 104
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 90
Clinical Trials 90
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 60
Diabetes Drugs 53
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,373 Results (Page 33 of 119)
- Relevance
  Sort by

Schizophrenia Drugs Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4496EUR$4,949USD£3,880GBP

Brain Tumor Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)

 Report
August 2020
114 Pages
Global

From

€3861EUR$4,250USD£3,332GBP

Diabetic Peripheral Neuropathy - Pipeline Insight, 2026

 Clinical Trials
April 2026
180 Pages
Global

From

€1817EUR$2,000USD£1,568GBP

Hepatitis C - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4315EUR$4,750USD£3,724GBP

Brain Tumor Treatment Market Report and Forecast 2023-2031

 Report
March 2023
147 Pages
Global

From

€4496EUR$4,949USD£3,880GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Specialty Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
180 Pages
Global

From

€4088EUR$4,500USD£3,528GBP

Liver Cancer Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Therapy; By Route of Administration; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2862EUR$3,150USD£2,470GBP

Glucocorticoid Induced Tumor Necrosis Factor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1136EUR$1,250USD£980GBP

Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030

 Report
November 2023
175 Pages
Global

From

€5405EUR$5,950USD£4,665GBP

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

 Report
November 2018
164 Pages
Global

From

€2134EUR$2,349USD£1,842GBP

Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028

 Drug Pipelines
March 2022
900 Pages
Global

From

€8176EUR$9,000USD£7,056GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

 Report
June 2024
64 Pages
Global

€9834EUR$11,204USD£8,200GBP

Canada Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

 Report
July 2024
80 Pages
Canada

From

€4315EUR$4,750USD£3,724GBP

Cryptococcosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
June 2025
189 Pages
Global

From

€4088EUR$4,500USD£3,528GBP

Systemic Lupus Erythematosus Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
180 Pages
Global

From

€7222EUR$7,950USD£6,233GBP

Psoriatic Arthritis - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7222EUR$7,950USD£6,233GBP

Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis

 Report
December 2023
146 Pages
Global

From

€13622EUR$14,995USD£11,757GBP

Minimal Change Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€1136EUR$1,250USD£980GBP

Nephrotic Syndrome - Pipeline Insight, 2025

 Drug Pipelines
April 2025
40 Pages
Global

From

€1136EUR$1,250USD£980GBP

Sickle Cell Disease Treatment Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

 Report
June 2025
400 Pages
Global

From

€4496EUR$4,949USD£3,880GBP

2,373 Results (Page 33 of 119)
- 1
- 31
- 32
- 33
- 34
- 35

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.